MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-12.23%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$636M
AUM Growth
+$636M
(-18%)
Cap. Flow
-$19.1M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
2
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$19.3M |
Top Sells
| 1 |
ProShares UltraPro Short S&P 500
SPXU
|
$14M |
| 2 |
ProShares UltraShort S&P500
SDS
|
$12.9M |
| 3 |
Exelixis
EXEL
|
$11.5M |
Sector Composition
| 1 | Healthcare | 96.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $354M | 55.63% | 15,966,038 -518,600 | -3% | -$11.5M |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $187M | 29.46% | 2,589,235 +266,400 | +11% | +$19.3M |
|
3
Alkermes
ALKS
$4.78B
| $59.7M | 9.4% | 1,030,639 | – | – |
|
4
Celldex Therapeutics
CLDX
$1.47B
| $14.7M | 2.31% | 6,312,700 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $10.5M | 1.65% | 400,000 | – | – |
|
6
iShares MSCI India ETF
INDA
$9.17B
| $9.9M | 1.56% | 290,000 | – | – |
|
|
7
ProShares UltraShort S&P500
SDS
$445M
| – | – | -315,000 | Closed | -$12.9M |
|
|
8
ProShares UltraPro Short S&P 500
SPXU
$527M
| – | – | -1,230,000 | Closed | -$14M |
|